Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase EARLY_PHASE1 3Phase 3 3Phase NA 2Phase 1 2Phase 4 1

Status

Completed 2Enrolling by invitation 1

Sponsor Class

OTHER 3NIH 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Barrett Esophagus 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Omeprazole × Clear all
NCT05680870 2025-09-09

The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients

Tanta University

Phase 3 Completed
46 enrolled
Gastrointestinal

Pancreatic Neoplasms, Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT07016737 2025-06-12

ESO-Nanjing12

Jiangsu Cancer Institute & Hospital

Phase 3 Enrolling by invitation
79 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT01566474 2019-09-13

Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study

Aragon Institute of Health Sciences

Phase 3 Completed
80 enrolled
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡